Journal
/
/
Rettet differensiering av Primitive og Definitive blodkreft Progenitors fra menneskelige Pluripotent stamceller
Journal JoVE
Biologie du développement
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Biologie du développement
Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
DOI:

14:37 min

November 01, 2017

,

Chapitres

  • 00:05Titre
  • 00:43Mesoderm Differentiation of hPSCs
  • 05:25Specification of CD34+ Hematopoetic Progenitors
  • 06:50Enzymatic Dissociation of EBs and Hematopoetic Progenitor Isolation
  • 08:23Endothelial-to-hematopoetic Transition
  • 10:18T Cell Assay
  • 11:38Results: Successful Differentiation of hPSCs
  • 14:13Conclusion

Summary

Traduction automatique

Her presenterer vi menneskelige pluripotent stamceller (hPSC) kultur protokoller, som brukes til å skille hPSCs i CD34+ blodkreft progenitors. Denne metoden bruker scenen-spesifikke manipulering av kanoniske WNT signalisering til å angi celler eksklusivt til enten definitive eller primitive blodkreft programmet.

Vidéos Connexes

Read Article